FDA APPROVAL PENDING
Emerging
Weight
Adipotide
25
Amino acids
Molecular weight
Peptide
Type
Chimeric adipose-vasculature-targeted peptidomimetic targeting prohibitin/annexin A2 on white adipose tissue endothelium, delivering pro-apoptotic D-(KLAKLAK)2 motif. In obese primates it produced rapid fat loss with improved insulin resistance, yet development halted after Phase 1 due to kidney safety signals.
CKGGRAKDC ligand homes to prohibitin/annexin A2 on white-fat endothelium; linked D-(KLAKLAK)2 disrupts mitochondrial membranes post-internalization, triggering localized endothelial apoptosis and adipocyte loss.
Lyophilized: -20°C freezer. Reconstituted: 2-8°C refrigerated
Once daily
0.43 mg/kg
28 days
Rapid fat-mass reduction via selective white adipose tissue vascular targeting
Improved insulin sensitivity following adipose reduction
Non-CNS peripheral mechanism distinct from appetite suppressants
This peptide is still gaining traction in the community.
Prohibitin-Targeting Peptidomimetic | Experimental Anti-Obesity
This overview is informational and based on aggregated descriptions from studies and user reports.
Was it helpful?YesView the scientifc details of Adipotide.
25
Amino Acids
Adipotide
Cys
Cys
Position 1
Lys
Lys
Position 2
Gly
Gly
Position 3
Gly
Gly
Position 4
Arg
Arg
Position 5
Ala
Ala
Position 6
Lys
Lys
Position 7
Asp
Asp
Position 8
Cys
Cys
Position 9
Gly
Gly
Position 10
Gly
Gly
Position 11
Lys
Lys
Position 12
Leu
Leu
Position 13
Ala
Ala
Position 14
Lys
Lys
Position 15
Leu
Leu
Position 16
Ala
Ala
Position 17
Lys
Lys
Position 18
Lys
Lys
Position 19
Leu
Leu
Position 20
Ala
Ala
Position 21
Lys
Lys
Position 22
Leu
Leu
Position 23
Ala
Ala
Position 24
Lys
Lys
Position 25
Rapid fat-mass reduction in obese non-human primates with improved insulin sensitivity; direct white adipose tissue vascular targeting.
| Goal | Dosage | Frequency | Route |
|---|---|---|---|
| Primate Research Replication | 0.43 | 1 week range | SubQ |
| Dose-Finding (Research) | 0.1 | 1 week range | SubQ |
Materials needed:
Steps to reconstitute
The Adipotide Cycle section explains how long a typical cycle lasts and what to expect during each phase. Over time, your body can become less responsive with continuous use.
Taking breaks between cycles may help maintain effectiveness and support better overall results.
Dosing tools
Calculate peptide doses with our visual syringe guide.
0.3mL / 30 units
5 units
0.050 mL
1 mL
2 mL
3 mL
5 mL
Custom
Conversion: 1,000 mcg = 1 mg
Based on your vial and dilution inputs.
Adipotide
SINGLE COMPOUNDVolume per injection
0.05
mL
Concentration
10.00
mg/mL
Doses per vial
20
doses
Total injections per vial
20 injections
How it works
Based on a 10 mg Adipotide vial diluted with 1 mL of bacteriostatic water, each 500 mcg injection equals 0.05 mL.
Research Purposes Only
These calculators are provided for educational and research purposes only. Always verify calculations and consult with qualified professionals. The information provided is not medical advice. Peptides should only be used in accordance with applicable laws and regulations.
Note: Triple agonist; microdose for fewer side effects
Research suggestions of Adipotide interactions with other common peptides and substances.
Weight
aod
Metabolic
MONITOR
No published data on combined use or pharmacodynamic interaction.
Healing
bpc
Longevity
COMPATIBLE
No known direct interaction; distinct mechanisms and targets.
Weight
cag
Metabolic
MONITOR
No clinical data on co-administration; mechanisms differ.
Skin
mela
Sexual
MONITOR
Theoretical vascular/pressor effects; stagger dosing, monitor BP and hydration.
Weight
sem
Metabolic
MONITOR
Potential additive dehydration/GI effects; monitor renal function.
Weight
tir
Metabolic
MONITOR
Overlapping weight-loss effects; monitor kidney function, volume status, electrolytes.
Monitor: Be careful when combining Adipotide with AOD-9604, Cagrilintide, Melanotan II, Semaglutide, Tirzepatide.
Pregnancy/lactation (not studied)
Dehydration
Concurrent nephrotoxic medications
Sustained creatinine elevation or oliguria
Progressive electrolyte abnormalities
Severe injection-site reactions or systemic symptoms
Unexpected toxicity
0.0
0 reviews
5
4
3
2
1
No comments yet
Be the first to share your experience. Your review helps others make more informed decisions.
Peptides can support cellular repair, immune function, metabolic health, and tissue regeneration. Research suggests they may help with recovery, sleep quality, skin health, and cognitive function, depending on the specific peptide and its mechanism of action.
Current research explores peptides for longevity, muscle recovery, wound healing, metabolic disorders, and neuroprotection. Scientists are also investigating peptide-based drug delivery and targeted therapies that could offer more precise treatment options.
Peptides work by binding to receptors on cells and triggering specific biological responses. Depending on the peptide, they may promote growth hormone release, support collagen production, modulate inflammation, or influence neurotransmitter activity—each with different implications for health and wellness.
Peer-reviewed journals such as Nature, Science, and specialized publications like Peptides and the Journal of Peptide Science publish ongoing research. PubMed and Google Scholar are useful for searching studies by peptide name or condition.
Research use of peptides typically follows institutional review board (IRB) protocols and regulatory guidelines. Dosage, administration route, and safety monitoring should align with published literature and applicable regulations in your jurisdiction.
Peptides are short chains of amino acids (typically under 50), while proteins are longer chains that fold into complex structures. Peptides are often more stable, easier to synthesize, and can cross cell membranes more readily, making them attractive for therapeutic applications.
Most peptides require refrigeration (2–8°C) and protection from light. Reconstituted peptides often have shorter stability and may need to be used within days or weeks. Always follow the manufacturer's or research protocol's storage instructions.
Some peptides are bioavailable orally, but many are broken down by digestive enzymes before reaching the bloodstream. Subcutaneous injection, nasal administration, or other routes are often used in research to improve bioavailability. The optimal route depends on the specific peptide.
Adipotide is an emerging compound
Adipotide
Adipotide is an emerging compound
A peptidomimetic targeting white fat causes weight loss and improved insulin resistance in obese monkeys
Rhesus macaques at 0.43 mg/kg SC daily for 28 days showed 7.4-14.7% weight loss; insulin resistance improved; mild, dose-dependent, reversible proximal tubule changes.
2011
Reversal of obesity by targeted ablation of adipose tissue
Mice with diet-induced obesity showed ~30% weight reduction; adipose vascular apoptosis; metabolic normalization.
2004
Prohibitin/Annexin A2 Interaction Regulates Fatty-Acid Transport
Mechanistic validation of prohibitin/ANXA2 axis in adipose tissue, core to TP01 targeting.
2016
Mixed-Chirality Prohibitin Peptide: D-(RLARLAR)2 Enhances Stability
Next-generation prohibitin constructs improve serum stability and efficacy vs. first-generation TP01.
2025